Disseminated superficial actinic porokeratosis

Disseminated superficial actinic porokeratosis (DSAP) is the most common form of porokeratosis characterized by the presence of several small annular plaques with a distinctive keratotic rim found most commonly on sun-exposed areas of the skin, particularly the extremities.



Input patient's signs and symptoms


Narrow down the case reports



Total: 27 (papers)

  


(per page)
Matched Phenotype  Gene  Mutation  MeSH
Rank
(Similarity)
PMID
(PMCID)
1
(17.5%)
21507038
Disseminated superficial actinic porokeratosis treated effectively with topical imiquimod 5% cream.
Arun B, Pearson J, Chalmers R.
Clin Exp Dermatol. 2011;36(5):509-11.
Erythema Scarring
Administration, Cutaneous Aminoquinolines Drug Administration Schedule Homo sapiens Interferon Inducers Male Porokeratosis
2
(4.0%)
29630163
A report and follow up of a patient with disseminated superficial actinic porokeratosis (DSAP) undergoing novel systemic treatment with palifermin (a keratinocyte growth factor) during chemotherapy.
Howard M, Hall A.
Dermatol Online J. 2018;24(2):.
Basal cell carcinoma
SERPINB3
Central Nervous System Neoplasms Follow-Up Studies Homo sapiens Lymphoma Male Porokeratosis Rosacea
2
(4.0%)
28976625
Amelanotic melanoma arising within a lesion of disseminated superficial actinic porokeratosis: An unusual presentation leading to a novel therapeutic approach.
Al-Haseni A, Chitgopeker P, Ho JD, Goldberg LJ, Sahni D.
Dermatol Ther. 2018;31(1):.
Melanoma
Administration, Cutaneous Antimetabolites, Antineoplastic Bandage Biopsy Females Homo sapiens Melanoma, Amelanotic Neoplastic Cell Transformation Porokeratosis Precancerous Conditions Skin Neoplasms
2
(4.0%)
28922948
Clinical and Dermoscopic Features of Pigmented Disseminated Superficial Actinic Porokeratosis: Case Report and Literature Review.
Sotoodian B, Mahmood MN, Salopek TG.
J Cutan Med Surg. 2018;22(2):229-231.
Erythematous papule
Back Biopsy Dermoscopy Homo sapiens Male Porokeratosis Skin Sunlight
2
(4.0%)
28398427
Disseminated superficial actinic porokeratosis treated with ingenol mebutate gel 0.05.
Anderson I, Routt ET, Jim On SC.
Cutis. 2017;99(3):E36-E39.
Actinic keratosis
Administration, Cutaneous Adult Dermatologic Agents Diterpenes Females Homo sapiens Porokeratosis
2
(4.0%)
27468973
Disseminated superficial actinic porokeratosis (DSAP): significant improvement after local administration of calcipotriol/betamethasone gel?
Tchernev G, Chokoeva AA, Ivanova B, Mangarov H, Vidolova NG.
Wien Med Wochenschr. 2017;167(3-4):85-88.
Basal cell carcinoma
Administration, Topical Aged, 80 and over Combination Drug Therapy Drug Administration Schedule Females Homo sapiens Leg Dermatoses Porokeratosis
2
(4.0%)
27086492
Linear porokeratosis with multiple squamous cell carcinomas successfully treated by electrochemotherapy.
Sommerlad M, Lock A, Moir G, McGregor J, Bull R, Cerio R, Harwood C.
Br J Dermatol. 2016;175(6):1342-1345.
Squamous cell carcinoma
Antibiotics, Antineoplastic Bowen's Disease Electrochemotherapy Homo sapiens Male Middle Aged Neoplastic Cell Transformation Porokeratosis Skin Neoplasms
2
(4.0%)
25800103
Eruptive disseminated porokeratosis associated with corticosteroid-induced immunosuppression.
Bednarek R, Ezra N, Toubin Y, Linos K, Mousdicas N.
Clin Exp Dermatol. 2015;40(7):753-6.
Asthma
Adrenal Cortex Hormones Adult Females Homo sapiens Immunosuppressive Agents Porokeratosis
2
(4.0%)
22148029
(3229955)
Squamous Cell Carcinoma Developing within Lesions of Disseminated Superficial Actinic Porokeratosis.
Lee HR, Han TY, Son SJ, Lee JH.
Ann Dermatol. 2011;23(4):536-8.
Squamous cell carcinoma
2
(4.0%)
21933257
Exclusive facial porokeratosis: histopathologically showing follicular cornoid lamellae.
Lee Y, Choi EH.
J Dermatol. 2011;38(11):1072-5.
Macule
Administration, Topical Adult Face Females Homo sapiens Porokeratosis
        

Phenotype(s) retrieved from Orphanet

    Total: 4

HPO ID Term Frequency
HP:0200044 Porokeratosis Very frequent (99-80%)
HP:0000992 Cutaneous photosensitivity Frequent (79-30%)
HP:0000989 Pruritus Occasional (29-5%)
HP:0002860 Squamous cell carcinoma Occasional (29-5%)


Phenotype(s) retrieved from case reports

    Total: 5

HPO ID Term # of case reports
HP:0002860 Squamous cell carcinoma 2
HP:0200034 Papule 2
HP:0002664 Neoplasm 1
HP:0020073 Hypopigmented macule 1
HP:0200039 Pustule 1


Causative gene(s) retrieved from Orphanet

    Total: 4

Gene Symbol Gene Name Entrez Gene ID
MVK mevalonate kinase 4598
SLC17A9 solute carrier family 17 member 9 63910
MVD mevalonate diphosphate decarboxylase 4597
FDPS farnesyl diphosphate synthase 2224